CRB proudly introduces its new Horizons series of industry reports, exploring key trends across the life sciences.  

From the global COVID-19 pandemic to rare and vexing health threats, our world seems forever on the defense against disease and in need of a nimble and efficient vaccine and therapy supply chain. 

Our Horizons: Cell and Gene Therapy report—built on a thorough survey of nearly 150 advanced therapy medicinal product industry leaders—analyzes the manufacturing processes, efficiencies and solutions that shape the world’s response to pandemics and other large-scale health dangers. How do we future-proof ATMP manufacturing to meet our world’s varied and unforeseen health threats head-on? 

CRB’s team of subject matter experts analyze the future of: 

  • Multimodal manufacturing  

  • Gene therapy manufacturing 

  • Facility optimization 

  • Project delivery 

  • Genetically-modified cell therapy 

  • Regulation 

Download your free copy today.